nodes	percent_of_prediction	percent_of_DWPC	metapath
Calcium Acetate—Vasospasm—Carmustine—lymphatic system cancer	0.052	0.052	CcSEcCtD
Calcium Acetate—Coma—Fludarabine—lymphatic system cancer	0.0254	0.0254	CcSEcCtD
Calcium Acetate—Stupor—Carmustine—lymphatic system cancer	0.0238	0.0238	CcSEcCtD
Calcium Acetate—Necrosis—Carmustine—lymphatic system cancer	0.0226	0.0226	CcSEcCtD
Calcium Acetate—Abscess—Carmustine—lymphatic system cancer	0.0224	0.0224	CcSEcCtD
Calcium Acetate—Necrosis—Mitoxantrone—lymphatic system cancer	0.021	0.021	CcSEcCtD
Calcium Acetate—Depressed level of consciousness—Carmustine—lymphatic system cancer	0.0171	0.0171	CcSEcCtD
Calcium Acetate—Coma—Carmustine—lymphatic system cancer	0.0162	0.0162	CcSEcCtD
Calcium Acetate—Coma—Vincristine—lymphatic system cancer	0.0155	0.0155	CcSEcCtD
Calcium Acetate—Haematuria—Fludarabine—lymphatic system cancer	0.0148	0.0148	CcSEcCtD
Calcium Acetate—Anorexia—Mechlorethamine—lymphatic system cancer	0.0146	0.0146	CcSEcCtD
Calcium Acetate—Arrhythmia—Teniposide—lymphatic system cancer	0.0142	0.0142	CcSEcCtD
Calcium Acetate—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.0133	0.0133	CcSEcCtD
Calcium Acetate—Arrhythmia—Fludarabine—lymphatic system cancer	0.0124	0.0124	CcSEcCtD
Calcium Acetate—Cardiac arrest—Vincristine—lymphatic system cancer	0.0117	0.0117	CcSEcCtD
Calcium Acetate—Confusional state—Teniposide—lymphatic system cancer	0.0114	0.0114	CcSEcCtD
Calcium Acetate—Oedema—Teniposide—lymphatic system cancer	0.0113	0.0113	CcSEcCtD
Calcium Acetate—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.0113	0.0113	CcSEcCtD
Calcium Acetate—Stupor—Methotrexate—lymphatic system cancer	0.011	0.011	CcSEcCtD
Calcium Acetate—Haematuria—Bleomycin—lymphatic system cancer	0.0109	0.0109	CcSEcCtD
Calcium Acetate—Pruritus—Mechlorethamine—lymphatic system cancer	0.0108	0.0108	CcSEcCtD
Calcium Acetate—Anorexia—Teniposide—lymphatic system cancer	0.0107	0.0107	CcSEcCtD
Calcium Acetate—Hypotension—Teniposide—lymphatic system cancer	0.0105	0.0105	CcSEcCtD
Calcium Acetate—Necrosis—Methotrexate—lymphatic system cancer	0.0105	0.0105	CcSEcCtD
Calcium Acetate—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.0105	0.0105	CcSEcCtD
Calcium Acetate—Abscess—Methotrexate—lymphatic system cancer	0.0104	0.0104	CcSEcCtD
Calcium Acetate—Confusional state—Fludarabine—lymphatic system cancer	0.00998	0.00998	CcSEcCtD
Calcium Acetate—Oedema—Fludarabine—lymphatic system cancer	0.0099	0.0099	CcSEcCtD
Calcium Acetate—Decreased appetite—Teniposide—lymphatic system cancer	0.00979	0.00979	CcSEcCtD
Calcium Acetate—Vomiting—Mechlorethamine—lymphatic system cancer	0.00971	0.00971	CcSEcCtD
Calcium Acetate—Anorexia—Fludarabine—lymphatic system cancer	0.00944	0.00944	CcSEcCtD
Calcium Acetate—Feeling abnormal—Teniposide—lymphatic system cancer	0.00928	0.00928	CcSEcCtD
Calcium Acetate—Nausea—Mechlorethamine—lymphatic system cancer	0.00908	0.00908	CcSEcCtD
Calcium Acetate—Paraesthesia—Fludarabine—lymphatic system cancer	0.00889	0.00889	CcSEcCtD
Calcium Acetate—Haematuria—Mitoxantrone—lymphatic system cancer	0.00881	0.00881	CcSEcCtD
Calcium Acetate—Decreased appetite—Fludarabine—lymphatic system cancer	0.00861	0.00861	CcSEcCtD
Calcium Acetate—Pain—Fludarabine—lymphatic system cancer	0.00847	0.00847	CcSEcCtD
Calcium Acetate—Constipation—Fludarabine—lymphatic system cancer	0.00847	0.00847	CcSEcCtD
Calcium Acetate—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00844	0.00844	CcSEcCtD
Calcium Acetate—Hypersensitivity—Teniposide—lymphatic system cancer	0.0083	0.0083	CcSEcCtD
Calcium Acetate—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00816	0.00816	CcSEcCtD
Calcium Acetate—Asthenia—Teniposide—lymphatic system cancer	0.00808	0.00808	CcSEcCtD
Calcium Acetate—Pruritus—Teniposide—lymphatic system cancer	0.00797	0.00797	CcSEcCtD
Calcium Acetate—Arrhythmia—Carmustine—lymphatic system cancer	0.00797	0.00797	CcSEcCtD
Calcium Acetate—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.00794	0.00794	CcSEcCtD
Calcium Acetate—Diarrhoea—Teniposide—lymphatic system cancer	0.00771	0.00771	CcSEcCtD
Calcium Acetate—Coma—Methotrexate—lymphatic system cancer	0.00752	0.00752	CcSEcCtD
Calcium Acetate—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00741	0.00741	CcSEcCtD
Calcium Acetate—Confusional state—Bleomycin—lymphatic system cancer	0.00732	0.00732	CcSEcCtD
Calcium Acetate—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00729	0.00729	CcSEcCtD
Calcium Acetate—Oedema—Bleomycin—lymphatic system cancer	0.00726	0.00726	CcSEcCtD
Calcium Acetate—Vomiting—Teniposide—lymphatic system cancer	0.00716	0.00716	CcSEcCtD
Calcium Acetate—Asthenia—Fludarabine—lymphatic system cancer	0.0071	0.0071	CcSEcCtD
Calcium Acetate—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00707	0.00707	CcSEcCtD
Calcium Acetate—Pruritus—Fludarabine—lymphatic system cancer	0.007	0.007	CcSEcCtD
Calcium Acetate—Anorexia—Bleomycin—lymphatic system cancer	0.00692	0.00692	CcSEcCtD
Calcium Acetate—Hypotension—Bleomycin—lymphatic system cancer	0.00678	0.00678	CcSEcCtD
Calcium Acetate—Diarrhoea—Fludarabine—lymphatic system cancer	0.00677	0.00677	CcSEcCtD
Calcium Acetate—Nausea—Teniposide—lymphatic system cancer	0.00669	0.00669	CcSEcCtD
Calcium Acetate—Paraesthesia—Bleomycin—lymphatic system cancer	0.00652	0.00652	CcSEcCtD
Calcium Acetate—Confusional state—Carmustine—lymphatic system cancer	0.00639	0.00639	CcSEcCtD
Calcium Acetate—Oedema—Carmustine—lymphatic system cancer	0.00634	0.00634	CcSEcCtD
Calcium Acetate—Decreased appetite—Bleomycin—lymphatic system cancer	0.00631	0.00631	CcSEcCtD
Calcium Acetate—Vomiting—Fludarabine—lymphatic system cancer	0.00629	0.00629	CcSEcCtD
Calcium Acetate—Pain—Bleomycin—lymphatic system cancer	0.00621	0.00621	CcSEcCtD
Calcium Acetate—Oedema—Vincristine—lymphatic system cancer	0.00605	0.00605	CcSEcCtD
Calcium Acetate—Anorexia—Carmustine—lymphatic system cancer	0.00604	0.00604	CcSEcCtD
Calcium Acetate—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00598	0.00598	CcSEcCtD
Calcium Acetate—Confusional state—Mitoxantrone—lymphatic system cancer	0.00594	0.00594	CcSEcCtD
Calcium Acetate—Hypotension—Carmustine—lymphatic system cancer	0.00592	0.00592	CcSEcCtD
Calcium Acetate—Oedema—Mitoxantrone—lymphatic system cancer	0.00589	0.00589	CcSEcCtD
Calcium Acetate—Nausea—Fludarabine—lymphatic system cancer	0.00588	0.00588	CcSEcCtD
Calcium Acetate—Shock—Mitoxantrone—lymphatic system cancer	0.00579	0.00579	CcSEcCtD
Calcium Acetate—Anorexia—Vincristine—lymphatic system cancer	0.00577	0.00577	CcSEcCtD
Calcium Acetate—Paraesthesia—Carmustine—lymphatic system cancer	0.00569	0.00569	CcSEcCtD
Calcium Acetate—Hypotension—Vincristine—lymphatic system cancer	0.00565	0.00565	CcSEcCtD
Calcium Acetate—Anorexia—Mitoxantrone—lymphatic system cancer	0.00561	0.00561	CcSEcCtD
Calcium Acetate—Decreased appetite—Carmustine—lymphatic system cancer	0.00551	0.00551	CcSEcCtD
Calcium Acetate—Hypotension—Mitoxantrone—lymphatic system cancer	0.0055	0.0055	CcSEcCtD
Calcium Acetate—Paraesthesia—Vincristine—lymphatic system cancer	0.00543	0.00543	CcSEcCtD
Calcium Acetate—Pain—Carmustine—lymphatic system cancer	0.00542	0.00542	CcSEcCtD
Calcium Acetate—Constipation—Carmustine—lymphatic system cancer	0.00542	0.00542	CcSEcCtD
Calcium Acetate—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00535	0.00535	CcSEcCtD
Calcium Acetate—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00529	0.00529	CcSEcCtD
Calcium Acetate—Decreased appetite—Vincristine—lymphatic system cancer	0.00526	0.00526	CcSEcCtD
Calcium Acetate—Feeling abnormal—Carmustine—lymphatic system cancer	0.00522	0.00522	CcSEcCtD
Calcium Acetate—Asthenia—Bleomycin—lymphatic system cancer	0.00521	0.00521	CcSEcCtD
Calcium Acetate—Constipation—Vincristine—lymphatic system cancer	0.00517	0.00517	CcSEcCtD
Calcium Acetate—Pain—Vincristine—lymphatic system cancer	0.00517	0.00517	CcSEcCtD
Calcium Acetate—Pruritus—Bleomycin—lymphatic system cancer	0.00514	0.00514	CcSEcCtD
Calcium Acetate—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00512	0.00512	CcSEcCtD
Calcium Acetate—Pain—Mitoxantrone—lymphatic system cancer	0.00504	0.00504	CcSEcCtD
Calcium Acetate—Constipation—Mitoxantrone—lymphatic system cancer	0.00504	0.00504	CcSEcCtD
Calcium Acetate—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00485	0.00485	CcSEcCtD
Calcium Acetate—Hypersensitivity—Carmustine—lymphatic system cancer	0.00467	0.00467	CcSEcCtD
Calcium Acetate—Vomiting—Bleomycin—lymphatic system cancer	0.00461	0.00461	CcSEcCtD
Calcium Acetate—Asthenia—Carmustine—lymphatic system cancer	0.00455	0.00455	CcSEcCtD
Calcium Acetate—Hypersensitivity—Vincristine—lymphatic system cancer	0.00446	0.00446	CcSEcCtD
Calcium Acetate—Haematuria—Methotrexate—lymphatic system cancer	0.00439	0.00439	CcSEcCtD
Calcium Acetate—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00434	0.00434	CcSEcCtD
Calcium Acetate—Asthenia—Vincristine—lymphatic system cancer	0.00434	0.00434	CcSEcCtD
Calcium Acetate—Diarrhoea—Carmustine—lymphatic system cancer	0.00433	0.00433	CcSEcCtD
Calcium Acetate—Nausea—Bleomycin—lymphatic system cancer	0.00431	0.00431	CcSEcCtD
Calcium Acetate—Asthenia—Mitoxantrone—lymphatic system cancer	0.00423	0.00423	CcSEcCtD
Calcium Acetate—Dizziness—Carmustine—lymphatic system cancer	0.00419	0.00419	CcSEcCtD
Calcium Acetate—Diarrhoea—Vincristine—lymphatic system cancer	0.00414	0.00414	CcSEcCtD
Calcium Acetate—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00403	0.00403	CcSEcCtD
Calcium Acetate—Vomiting—Carmustine—lymphatic system cancer	0.00403	0.00403	CcSEcCtD
Calcium Acetate—Dizziness—Vincristine—lymphatic system cancer	0.004	0.004	CcSEcCtD
Calcium Acetate—Vomiting—Vincristine—lymphatic system cancer	0.00385	0.00385	CcSEcCtD
Calcium Acetate—Nausea—Carmustine—lymphatic system cancer	0.00376	0.00376	CcSEcCtD
Calcium Acetate—Vomiting—Mitoxantrone—lymphatic system cancer	0.00375	0.00375	CcSEcCtD
Calcium Acetate—Nausea—Vincristine—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Calcium Acetate—Dysgeusia—Methotrexate—lymphatic system cancer	0.00352	0.00352	CcSEcCtD
Calcium Acetate—Nausea—Mitoxantrone—lymphatic system cancer	0.0035	0.0035	CcSEcCtD
Calcium Acetate—Confusional state—Methotrexate—lymphatic system cancer	0.00296	0.00296	CcSEcCtD
Calcium Acetate—Anorexia—Methotrexate—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Calcium Acetate—Hypotension—Methotrexate—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Calcium Acetate—Paraesthesia—Methotrexate—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Calcium Acetate—Decreased appetite—Methotrexate—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Calcium Acetate—Pain—Methotrexate—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Calcium Acetate—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Calcium Acetate—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Calcium Acetate—Asthenia—Methotrexate—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Calcium Acetate—Pruritus—Methotrexate—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Calcium Acetate—Diarrhoea—Methotrexate—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Calcium Acetate—Dizziness—Methotrexate—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Calcium Acetate—Vomiting—Methotrexate—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Calcium Acetate—Nausea—Methotrexate—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
